Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori
This study revealed a decreasing incidence of gastric noncardia adenocarcinoma after H pylori eradication treatment in 5 Western populations. The risk became virtually similar to the background population from 11 years after treatment.
Authors
- Helgi Birgisson (ORCID: https://orcid.org/0000-0002-8246-6159)
- Giola Santoni (ORCID: https://orcid.org/0000-0002-9094-5037)
- Joonas H. Kauppila (ORCID: https://orcid.org/0000-0001-6740-3726)
- Jesper Lagergren (ORCID: https://orcid.org/0000-0002-5143-5448)
- My von Euler‐Chelpin (ORCID: https://orcid.org/0000-0003-2204-7048)
- Cecilia Radkiewicz (ORCID: https://orcid.org/0000-0003-0683-1537)
- Eivind Ness‐Jensen (ORCID: https://orcid.org/0000-0001-6005-0729)
- Shao-Hua Xie (ORCID: https://orcid.org/0000-0003-0864-8154)
- Jane Yan
- Anna-Klara Wiklund (ORCID: https://orcid.org/0000-0003-0974-3284)
Institutions
- University of Copenhagen (DK)
- Karolinska University Hospital (SE)
- Oulu University Hospital (FI)
- Levanger Hospital (NO)
- Karolinska Institutet (SE)
- Icelandic Cancer Society (IS)
Publication Details
- Journal
- Gastroenterology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1053/j.gastro.2025.01.239
- Citations
- 24
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 48.15
Funders
- Sjöbergstiftelsen
- Stockholms Läns Landsting
- Cancerföreningen i Stockholm